Clinical Trial Update: Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating EG-1962 versus standard nimodipine in adults with aneurysmal subarachnoid hemorrhage has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• EG-1962
• Nimodipine (Nimodipine)

Snippet

Sponsor: Edge Therapeutics Inc | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 3 | Status: TERMINATED